Ovid Therapeutics Inc. Annual Operating Margin in % from 2021 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Ovid Therapeutics Inc. quarterly/annual Operating Margin history and growth rate from 2021 to 2023.
  • Ovid Therapeutics Inc. Operating Margin for the quarter ending September 30, 2024 was -11K %, a 38.9% increase year-over-year.
  • Ovid Therapeutics Inc. annual Operating Margin for 2023 was -15.1K %, a 309% decline from 2022.
  • Ovid Therapeutics Inc. annual Operating Margin for 2022 was -3.7K %, a 6301% decline from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -15.1K -11.4K -309% Jan 1, 2023 Dec 31, 2023
2022 -3.7K -3.76K -6301% Jan 1, 2022 Dec 31, 2022
2021 59.6 Jan 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.